Omeros | OMER - Операционные расходы





Операционные расходы Изменить Дата
Adma Biologics USD 71.95M 7.75M 2026-06
Alnylam Pharmaceuticals USD 1.11B 52.78M 2026-09
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Cytokinetics USD 214.64M 6.85M 2026-09
Gilead Sciences USD 13.04B 9.09B 2026-09
Heron Therapeutics USD 40.55M 1.46M 2025-12
Immunic USD 23.33M 2.67M 2025-12
Insmed USD 606.26M 79.46M 2026-09
Knight Therapeutics CAD 126.9M 8.29M 2025-12
MacroGenics USD 42.87M 21.68M 2026-06
Omeros USD 59.16M 20.13M 2024-06
Pacira USD 1.18B 995.96M 2026-09
Pfizer USD 89B 3.81B 2026-09
Rockwell Medical USD 30.41M 1.11M 2025-06
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
United Therapeutics USD 6.28B 124.3M 2026-09
Vertex Pharmaceuticals USD 2.18B 118.2M 2026-09